The News
Jean Schmitt named managing Partner at Sofinnova Partners
24/03/2005
Paris, 24 March 2005 – Sofinnova Partners is pleased to announce that Jean Schmitt has been promoted to Managing Partner.
Jean Schmitt, 39, joined Sofinnova Partners’ Information Technology team as Partner in December 2001. He is particularly interested in opportunities in new technologies in the telecommunications sector. At Sofinnova he has focused on mobile telephony, investing in embedded software such as Java Virtual Machines (Esmertec), mobile game technologies (InfraWorlds), fingerprint sensors (UPEK), and acoustic-based tactile user interfaces (Sensitive Object). He is a board member of Esmertec, UPEK, InfraWorlds, Sensitive Object and CTS.
Prior to joining Sofinnova Partners, Jean was the founder of several companies, including SLP InfoWare, a world leader in predictive customer relationship management software for the telecom industry, which he sold to Gemplus in 2000. He is a graduate of the Ecole Nationale Supérieure des Télécommunications (ENST) and has a post-graduate degree in Artificial Intelligence.
“This promotion reflects the excellent contribution Jean has made to the IT team and to the partnership,” said Jean-Bernard Schmidt, Chairman and a Managing Partner. “It also reflects our full confidence as we begin investing our new fund.” Sofinnova Capital V closed in early February at €385 million.
For further information, please contact:
Madeleine Resener
Media Relations
Sofinnova Partners
Tel: +33 (0) 53 05 41 00 / +33 (0) 6 20 41 39 82
mresener@sofinnova.fr
About Sofinnova Partners
Founded in Paris in 1972, Sofinnova Partners is one of Europe's leading independent venture capital firms. With €900 million under management, Sofinnova Partners invests in start-ups and early-stage companies in information technology and life sciences. Its investment strategy consists of investing early in teams and projects with high potential, most often acting as lead or co-lead investor. Sofinnova Partners also benefits from a long-established relationship with its sister company in San Francisco, Sofinnova Ventures. Sofinnova Partners’ teams consist of 12 professionals who bring market insight and technical expertise to portfolio companies.
2005
- 03/01/2005
- 01/01/2005
- 05/01/2005
- 10/01/2005
- 17/01/2005
- 17/01/2005
- 19/01/2005
- 27/01/2005
-
27/01/2005
XYOTAXTM Pivotal Trial in Non-Small Cell Lung Cancer, STELLAR 3, Reaches Required Number of Events
-
28/01/2005
Esmertec and MontaVista Software to deliver integrated Java-Linux solutions for mobile phones
-
28/01/2005
Esmertec et MontaVista Software proposent des solutions Java-Linux intégrées pour terminaux Mobiles
- 02/02/2005
-
02/02/2005
Esmertec acquiert la Division Mobile de CoreTek Systems, en Chine
- 07/02/2005
- 07/02/2005
-
08/02/2005
XYOTAX Patent Allowance Provides Exclusivity in Europe Until 2017
-
08/02/2005
WebSideStory Announces Agreement to Acquire Atomz and Launch of Active Marketing Suite
-
16/02/2005
Important soutien financier en faveur des recherches sur le cancer de DIATOS N.V.
-
16/02/2005
DIATOS N.V.’s oncology research boosted by significant funding
- 22/02/2005
- 22/02/2005
- 08/03/2005
-
10/03/2005
Sofinnova Parners voted European VC Firm of the year in Global Private Equity Awards
-
10/03/2005
Sofinnova Parners voted European VC Firm of the year in Global Private Equity Awards
- 16/03/2005
-
16/03/2005
Varioptic to demonstrate the world's first liquid zoom lens for camera phones at Cebit
- 15/03/2005
- 17/03/2005
-
22/03/2005
CoTherix's Ventavis(R) Commercially Available for the Treatment of Pulmonary Arterial Hypertension
-
22/03/2005
CoTherix's Ventavis(R) Commercially Available for the Treatment of Pulmonary Arterial Hypertension
-
24/03/2005
Jean Schmitt named managing Partner at Sofinnova Partners
-
24/03/2005
Nomination de Jean Schmitt comme Partenaire-Associé chez Sofinnova Partners
- 24/03/2005
- 24/03/2005
- 06/04/2005
- 06/04/2005
- 08/04/2005
- 08/04/2005
- 04/04/2005
-
12/04/2005
Neuro3d Reports Positive Results from Phase II Trials of Ocaperidone in Schizophrenia
-
12/04/2005
Diatos S.A. opens its US subsidiary in California - Diatos USA, Inc.
- 14/04/2005
-
26/04/2005
GPC Biotech and Ingenium Receive € 2.2 Million Joint Drug Discovery Grant from German Ministry
-
26/04/2005
GPC Biotech and Ingenium Receive € 2.2 Million Joint Drug Discovery Grant from German Ministry
- 12/05/2005
-
12/05/2005
6WIND announces R&D partnership with China academy of science
- 16/05/2005
- 16/05/2005
-
16/05/2005
New Ventavis(R) Data to Be Presented at American Thoracic Society's International Conference
-
16/05/2005
New Ventavis(R) Data to Be Presented at American Thoracic Society's International Conference
-
17/05/2005
DIATOS and SERVIER announce oncology research collaboration using the VECTOCELL® technology
-
17/05/2005
DIATOS and SERVIER announce oncology research collaboration using the VECTOCELL® technology
-
17/05/2005
DIATOS S.A. opens its US subsidiary in California – DIATOS USA, INC.
-
17/05/2005
DIATOS S.A. opens its US subsidiary in California – DIATOS USA, INC.
- 19/05/2005
- 23/05/2005
- 19/05/2005
- 23/05/2005
- 23/05/2005
- 23/05/2005
-
07/06/2005
OXXIUS Shrinks DPSS Lasers and announces world’s smallest blue laser module
-
07/06/2005
OXXIUS Shrinks DPSS Lasers and announces world’s smallest blue laser module
- 20/06/2005
-
20/06/2005
Sofinnova Partners investit 4 millions d'euros dans Endotis Pharma
- 14/06/2005
- 14/06/2005
-
27/06/2005
Esmertec et LG Electronics présentent un mobile doté d’une JVM (Java Virtual Machine) multi-tâches
-
27/06/2005
Esmertec and LG Electronics Demonstrate Multi-tasking Java Virtual Machine on a Mobile Handset
-
28/06/2005
Revolt technology receives €7 million in first round of financing
- 05/07/2005
- 08/07/2005
-
06/07/2005
Esmertec officially opened its R&D and Customer Support Center in Chengdu, China
- 28/07/2005
- 22/08/2005
-
16/08/2005
Epimmune and IDM S.A. Join Forces to become IDM Pharma, Inc.
-
16/08/2005
Epimmune et IDM S.A. fusionnent pour devenir IDM PHARMA, INC.
-
25/07/2005
UPEK® provides Biometric Finger security for the THINKPAD* Tablet
-
21/07/2005
InfraWorlds acquiert 995 SOFT et entre sur le marché américain
-
25/07/2005
Infraworlds crée un nouveau format de jeu grand public : SagaZ
- 25/07/2005
-
03/08/2005
Infraworlds creates SagaZ, a new game format for the mass market
- 26/07/2005
- 28/07/2005
- 22/08/2005
- 22/08/2005
- 30/08/2005
-
31/08/2005
NEC Infrontia fait de Jbed CDC, la plate-forme Java d’Esmertec, son standard JVM
- 31/08/2005
-
06/09/2005
Varioptic expands its focus to deliver liquid lenses in new markets
- 26/09/2005
-
30/09/2005
VoluBill announces “Charge it” – a comprehensive mobile data charging solution
- 03/10/2005
- 30/09/2005
-
05/10/2005
Sofinnova Partners annonces the successful stock market flotations of two portfolio companies
- 17/10/2005
- 25/10/2005
- 20/10/2005
- 07/11/2005
- 14/11/2005
- 10/11/2005
-
23/09/2005
Servista wins "BPO Service Provider of the Year" at NOA awards ceremony 2005
- 15/11/2005
-
22/11/2005
Tsinghua Tongfang and 6Wind partnership to take China's booming ICT market by storm
-
22/11/2005
Tsingha Tongfang et 6Wind à la conquête du marché chinois des TIC
-
17/11/2005
6Wind contributes to success of KDDI's mobile broadband project
-
17/11/2005
6Wind contribue au succès du projet de réseau mobile haut débit mené par l'opérateur japonnais KDDI
- 21/11/2005
-
21/11/2005
Howard Ford former Managing Director of Equant joins Varioptic as Chairman of the Board Lyon, France
- 19/10/2005
- 24/11/2005
- 06/12/2005
-
13/12/2005
CoTherix and Respironics Announce Launch of New Portable Inhalation Device to Ventavis Patients
- 13/12/2005
- 13/12/2005
-
14/12/2005
Professor Peter Van Brummelen and DR. Annick Schwebig join the board of directors of Diatos S.A.
- 29/11/2005
- 26/12/2005
- 23/12/2005